4//SEC Filing
Stolz Brian M. 4
Accession 0000899243-20-022790
CIK 0001743881other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 7:02 PM ET
Size
9.5 KB
Accession
0000899243-20-022790
Insider Transaction Report
Form 4
Stolz Brian M.
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2020-08-16$28.53/sh−552$15,749→ 24,615 total - Exercise/Conversion
Common Stock
2020-08-16+1,595→ 25,167 total - Exercise/Conversion
Restricted Stock Units
2020-08-16−1,595→ 23,937 total→ Common Stock (1,595 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Includes 733 shares acquired by the Reporting Person on August 14, 2020 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
- [F3]Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 1,595 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.
- [F4]The RSUs vest over approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. 6.25% of the RSUs vested on August 16, 2020 and an additional 6.25% will vest in quarterly installments on the 16th day of each February, May, August and November thereafter, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001524803
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 7:02 PM ET
- Size
- 9.5 KB